Our findings reveal that GzB expression is more than just a phenotypic characteristic of ALK+ ALCL lymphoma cells, as expression of this serine protease sensitizes ALK+ ALCL tumour cells to drug-induced apoptosis. Here, ALK is linked to lymphoma.